NON SMALL CELL LUNG CANCER (STAGE III)
Clinical trials for NON SMALL CELL LUNG CANCER (STAGE III) explained in plain language.
Never miss a new study
Get alerted when new NON SMALL CELL LUNG CANCER (STAGE III) trials appear
Sign up with your email to follow new studies for NON SMALL CELL LUNG CANCER (STAGE III), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Cancer-Fighting virus takes on lung cancer in new trial
Disease control Recruiting nowThis study tests a new approach for people with advanced lung cancer whose disease got worse after initial treatment. It combines an injected virus (Olvi-Vec) that attacks cancer cells, followed by standard chemotherapy plus an immunotherapy drug, and compares it to standard chem…
Matched conditions: NON SMALL CELL LUNG CANCER (STAGE III)
Phase: PHASE2 • Sponsor: Genelux Corporation • Aim: Disease control
Last updated May 17, 2026 05:35 UTC
-
New combo shrinks lung tumors before surgery in phase 2 trial
Disease control Recruiting nowThis study tests whether giving chemotherapy plus an immunotherapy drug (cemiplimab) before surgery can help people with stage 3 non-small cell lung cancer that has spread to certain lymph nodes. About 21 adults will receive four cycles of the combination, then have surgery to re…
Matched conditions: NON SMALL CELL LUNG CANCER (STAGE III)
Phase: PHASE2 • Sponsor: Georgetown University • Aim: Disease control
Last updated May 15, 2026 11:56 UTC
-
Blood test detects hidden cancer, guides targeted therapy to stop lung cancer return
Disease control Recruiting nowThis study uses a sensitive blood test (ctDNA) to find tiny amounts of cancer left after standard treatment for early-stage non-small cell lung cancer. If the test is positive, participants receive the drug durvalumab to try to clear the remaining cancer cells and lower the chanc…
Matched conditions: NON SMALL CELL LUNG CANCER (STAGE III)
Phase: PHASE2 • Sponsor: Stanford University • Aim: Disease control
Last updated May 15, 2026 11:53 UTC
-
Lung cancer survivors may breathe easier with rehab program, new study suggests
Symptom relief Recruiting nowThis study looks at whether an 8-week pulmonary rehabilitation program can help people with advanced non-small cell lung cancer who have trouble breathing and feel tired. Half of the 85 participants will do the rehab program, while the other half will get their usual care. Resear…
Matched conditions: NON SMALL CELL LUNG CANCER (STAGE III)
Phase: PHASE2 • Sponsor: Case Comprehensive Cancer Center • Aim: Symptom relief
Last updated May 17, 2026 05:49 UTC
-
Lung cancer study tracks immune response after standard treatments
Knowledge-focused Recruiting nowThis study observes how the immune system responds after standard chemo-radiation followed by immunotherapy in patients with stage III non-small cell lung cancer that cannot be removed by surgery. Researchers will review medical records from about 50 participants to see how long …
Matched conditions: NON SMALL CELL LUNG CANCER (STAGE III)
Sponsor: Fundación GECP • Aim: Knowledge-focused
Last updated May 17, 2026 05:34 UTC
-
New radiation technique aims to protect heart during cancer treatment
Knowledge-focused Recruiting nowThis study tests whether a newer type of radiation therapy (MRgART) is gentler on the heart than standard radiation (LINAC) for people with cancers like lung or esophageal cancer near the heart. About 60 adults will receive radiation and have their heart function checked with MRI…
Matched conditions: NON SMALL CELL LUNG CANCER (STAGE III)
Phase: PHASE2 • Sponsor: University of Wisconsin, Madison • Aim: Knowledge-focused
Last updated May 13, 2026 16:01 UTC